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I, INTRODUCTION 
The discoveries made at the end of the 19th centruy 
concerning the importance of infectious micro-organisms in 
human disease provoked great interest in the physiologic 
response of the body to infection* It was at this time that 
the biology of inflammation was first carefully studied and 
accurately described. In 1882 Julius Cohnheim presented his lect¬ 
ures describing the microscopic vascular events which occur in 
acutely inflammed tissues as he observed them in the mesentery 
and tongue of the frog; from his descriptions -- of vascular dila¬ 
tation, transudation of fluid, margination of white cells against 
vessel walls and migration of the white cells into the extra- 
vascular spaces -- have sprung several channels of basic re¬ 
search on mechanisms of acute inflammation,^ 
Soon after Cohnheim*s reports, Elie MetchniRoff 
clarified the role of the inflammatory process and particularly 
of polymorphonuclear leukocytes (neutrophils) in natural pro¬ 
tection against inflammatory disease, "The diapedesis of the white 
corpuscles, their migration through the vessel wall into the 
cavities and tissues, is one of the principal means of defence 
possessed by an animal. As soon as the infective agents have 
penetrated into the body, a whole army of white corpuscles pro¬ 
ceed towards the menaced spot, there entering into a struggle 
2 
with the micro-organisms." 
Metchnikoff represented the tissue damage of acute 
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inf lamination largely through military metaphors -- the necessary 
result of battles between the invading microbe and host. How¬ 
ever, his studies recognized the importance of digestive "fer¬ 
ments" and "cytases" contained in neutrophils for the function of 
these cells, "The leukocytes, having arrived at the spot where 
the intruders are found, seize them after the manner of Amoebae 
and within their bodies subject them to intracellular digestion. 
This digestion takes place in the vacuoles in which usually is 
3 
a weakly acid fluid which contains digestive ferments," 
Since the turn of the century, the "ferments" and 
the process of phagocytosis have been studied with more refine¬ 
ment by techniques of modern cell biology and enzymology. In 
particular, the digestive enzymes contained in neutrophils have 
been studied as they act as mediators of the tissue damage in 
acute inflammation. The release of these digestive enzymes during 
phagocytosis is the subject of several studies with human neu¬ 
trophils _in vitro to be presented in this report. 
It had been proposed at the time of Metchnikoff’s 
studies that oneof the functions of inflammatory leukocytes might 
be to deliver bactericidal substances to the sites of infection, 
for it was known that white cell extracts lent bactericidal 
properties to normal serum, Metchnikoff’s observations, however, 
led him to believe that the neutrophils1 bactericidal "ferments" 
served essentially the mechanisms of phagocytosis and intracell¬ 
ular digestion of foreign particles or microbes and were released 

into the tissues only with the disruption of these cells, "The 
cytases must be grouped with the soluble ferments which are not 
thrown off by the phagocytes as long as these remain intact. Im¬ 
mediately these cells are injured, however, they allow a part of 
their cytases to escape," 
Interest in the character and function of the pro¬ 
teolytic and other hydrolytic enzymes contained in neutrophils 
has focused not only on the role of these enzymes in the 
protection against infecting micro-organisms but also on their 
role in processes that are themselves harmful to the body. As 
soon as the protective function of inflammation was recognized, 
it was also recognized that the inflammatory process could be 
misdirected and could itself produce disease. 
Experimentation with models of inflammation wherein 
the inflammatory response rather than the inflammatory stimulus 
is harmful has accompanied the increasing study and recognition 
of diseases associated with diffuse or localized inflammation 
which offers no apparent protective function. Among these 
diseases are the so-called "immune complex" vasculitides, post¬ 
streptococcal glomerulonephritis, and acute gouty arthritis. 
The Arthus Phenomenon, in particular, first described 
in 1903, has been an experimental archetype of misdirected 
inf lamination.J Arthus observed that once an experimental animal 
is immunized against a foreign protein, this protein injected 
into the skin of the animal provokes an inflammatory response 
at the site of injection resulting in tissue necrosis. It was 

demonstrated subsequently that this tissue damage is a direct 
consequence, not of the antigen-antibody complexes which form in 
the skin of the experimental animal, but of the classic events of 
inflammation which are provoked by these protein complexes,^^ 
Neutrophils are attracted to the sites where deposition of an¬ 
tigen-antibody complexes occurs, and there they phagocytize 
6 7 8 
these complexes, 1 ' * The tissue damage resulting from the exper¬ 
imental inflammation in the Arthus Phenomenon depends upon the 
presence of neutrophils in the tissues. Tissue damage does not 
occur when neutrophils are prevented from accumulating either 
° 10 11 by rendering the animal leukopenic ’ or by inhibiting 
reactions in the blood complement system, initiated by the form¬ 
ation of antigen-antibody complexes, which attract neutrophils 
12 13 to the experimental site, * 
A model of misdirected inflammation which has been 
explored similarly is one in which urate crystals are infused 
into the joints of humans or animals; the crystals provoke an 
acute inflammation in which the inflammatory exudate consists 
primarily of neutrophils, which may be observed to phagocytize the 
crystals. - - Infusion of urate crystals into leukopenic ani¬ 
mals results neither in inflammation nor in tissue injury,1 
Investigations concerning the mechanisms of tissue 
injury produced by phagocytizing neutrophils in these experi¬ 
mental models have commanded particular interest in recent 
years, for an understanding of these mechanisms promises the 
eventual control of various inflammatory diseases. One of the 
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first proposals which related tissue injury to the 
accumulation of neutrophils in the inflammatory response was 
that the concentrations of lactic acid produced by accumulated 
neutrophils are toxic to tissues,^ *1 It has been well demon¬ 
strated that an increased production of lactic acid by neutrophils 
occurs during phagocytosis and under anaerobic conditions? also, 
direct measurements of pH in inflammatory, transudative fluids 
in which neutrophil accumulation occurs have shown a fall in 
19 pH over time as a function of the number of neutrophils present.' 
More recently, however, attention has turned to the various di¬ 
gestive enzymes contained in neutrophils as important med¬ 
iators of tissue injury in acute inflammation. 
By the mid-l9509s it was known that neutrophils con¬ 
tain enzymes capable of degrading polymers of amino-acids, 
carbohydrates, lipids, and phosphorylated or sulphated compounds 
and are thus well equipped for the digestion of a variety of 
22 23 tissue substrates, ’ A significant advance in understanding 
the mobilization of these enzymes was made when it was recognized 
that the enzymes are stored in intracellular organelles long 
characterized morphologically as "granules," In 1955 De Duve 
described in rat liver cells a class of cytoplasmic organelles, 
"lysosomes," which contain several distinct acid hydrolytic 
enzymes? these enzymes were found to exhibit activity only 
when released from the organelles into a soluble phase." *36 
It was recognized that enzymes contained in neutrophil granules 
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behave after the manner of lysosomal enzymes in that they ex- 
27 hibit activity only when the intact granules are disrupted. 
Morphological studies of phagocytizing neutrophils, with both 
light and electron microscopy, have elucidated the mechanism 
by which their "lysosomal" enzymes are mobilized for the digestion 
of phagocytized particles? the membrane shell of the granules 
fuses with the membrane enclosing the phagocytic vacuole con¬ 
taining an ingested particle, and therby the granules release 
their enzymes into the vacuoles. In this way the neutrophil is 
"degranulated" during phagocytosis,- ”32 
Various enzymes isolated from neut»phil granules have 
been shown to be active in degrading tissue constituents? col- 
lagenase, neutral protease, elastase, and acid cathepsins have 
been variously described, active individually or together against 
collagen, protein polysaccharides, elastin, arterial cell walls, 
and isolated vascular basement membrane,^(review) These en¬ 
zymes have been identified in neutrophil granules together with 
27 
various acid hydrolases present in lysosomes of other cell types ? 
with certain enzymes or proteins that have specific anti-bacter¬ 
ial activity (Lysozyme,"Leukin," and "Phagocytin") * 4;? and with 
a group of "basic cationic proteins" which togetner with bacter: • 
p 9 / 9 O 9 p -5 
cida1 actions cause increased vascular permiaoility, * 
Although mechanisms have been shown for the mobili¬ 
zation of these various substances in the intracellular digestion 
of phagocytized particles, mechanisms for the release of these 
granular substances extra-cellularly have been less clear. 
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There is strong circumstantial evidence, however, that lysosomal 
enzymes and proteins are released from neutrophils and play an 
important part in the tissue damage of acute inflammation. Evi- 
dnece for this already mentioned includes: 1) experimental models 
of acute inflammation in which neutrophils must be present in 
tissues for tissue injury to occur, 2) the activity of neutrophil 
granular enzymes in degrading various tissue constituents. Evi¬ 
dence that neutrophil granular enzymes mediate tissue injury also 
includes: 3) the experimental production of tissue damage by di¬ 
rect infusion of neutrophil granule suspensions or granule ex¬ 
tracts into the skin of animals, > • '• 4) the inhibition 
by certain anti-inflammatory drugs of experimentally induced 
diruption of isolated lysosomes _in vitro, or inhibition of 
neutrophil degranulation during phagocytosis. <-,»->^»40,4I 
It will be remembered that Metchnikoff in his orig¬ 
inal reports argued against the proposition that "cytases'’ 
escape from neutrophils during their normal function. Since 
1960, however, several studies with human and non-human neutro¬ 
phils j^n vitro have shown that a portion of their granular enzymes 
are extruded when these cells phagocytize various paricles -- 
bacteria, immune complexes, yeast and starch granules,33,42-52 
Studies to be presented in this report provide direct 
evidence that neutrophil granular enzymes not only disappear 
from these cells during phagocytosis but also appear in the 
surrounding media in which the leukocytes are phagocytizing part¬ 
icles, Also these studies demonstrate that the immediate fate 
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of granular enzymes during phagocytosis depends in part upon 
the respective stabilities of these enzymes in soluble phase. 
Furthermore, these studies demonstrate that the release of gran¬ 
ular enzymes from phagocytizing leukocytes may be inhibited 
by certain anti-inflammatory drugs (colchicine and cortisol) 
but not by another such drug (salicylate). 

_Q _ 
II. THE RELEASE OF LYSOZYME FROM HUMAN LEUKOCYTES 
DURING PHAGOCYTOSIS 
Experiments with rabbit neutrophils .in. vitro have 
demonstrated that various granule-bound enzymes are redistrib¬ 
uted within the cells as a consequence of phagocytosis of bac¬ 
teria; these enzymes were reported to be released from the gran¬ 
ule fraction of the cells into the cytoplasm or soluble fraction 
41 
of the cells. In these studies only small amounts of granular 
enzyme activities were recovered from the extra-cellular medium 
of the phagocytizing cells, and no decrease of net intracellular 
42 
enzyme activities was found to occur. Subsequent studies with 
human leukocytes jin. vitro were reported to demonstrate a compar¬ 
able redistribution of granular enzymes intracellularly when these 
cells phagocytized immune complexes (Gamma G - Rheumatoid Factor); 
similarly these studies did not report significant losses of 
enzyme activities from the leukocytes. 4 
More recently, however, several studies have been re¬ 
ported which demonstrate or suggest significant release of gran¬ 
ule associated enzymes from neutrophils consequent to phagocytosis 
of a variety of particles in vitro. Both human^10 * '"f * > 51 and 
rabbit" neutrophils have been used in these experiments; 
enzymes shown to be released into the extra-cellular media of 
phagocytizing cells include: lysozyme?"*'" ’ acid phosphatase? *~" 
acid protease (cathepsin) ,“ * " B-glucuronidase, 6>^ * " alk¬ 
aline phosphatase,^ and peroxidase,14 Release of granular enzymes 
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has been reported to occur with phagocytosis of bacteria (E. coli, 1 
Bacillus subtilis"," M. lysodeikticus, ' and Staphylococci' ), 
immune complexes (bovine serum albumin-anti BSA,precipitates 
/ c 
of Staphylococcus cell-wall antigens in specific immune sera ), 
and inert particles (globulin coated latex beads," zymozan part¬ 
icles,"1 >- ■ and starch granules1^ . 
In the following experiments I have investigated the 
intracellular redistribution and the extra-cellular release of lysozyme 
from human leukocytes during phagocytosis of Staphylococcus, 
let hods 
Glassware: 
All glassware used in these experiments was made sterile 
and pyrogen free by heating st 163°C for 2 hrs. In addition, 
glassware used in the isolation and incubation of leukocytes 
(pipettes, centrifuge tubes, and flasks) was siliconized to pre¬ 
vent sticking of the cells to the glass. 
40 
Isolation of Leukocytes from Human Blood: 
Up to 150 ml of blood was drawn from the antecubital 
veins of normal volunteers; the blood was heparinized (10 mg/100 ml), 
mixed with 2 vol. of Dextran solution and allowed to sediment 
in 100 ml cylinders at room temperature for 20-30 min. The leuk¬ 
ocyte rich supernatant was then centrifuged in 50 ml tubes at 
1200 rpm (800 g) in an International Centrifuge, model PR-2, for 
15 min. The new supernatant was removed and the cell button re- 
3% Dextran of M.W. 100,000-200,000 (Nutritional Biochemical Corps,, 
Cleveland, Ohio) in normal saline, autoclaved for 2 hrs and stored 
at 4°C. 
■ 
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suspended in modified Krebs-Ringer phosphate buffer at pH 7.4. 
The resulting cell suspensions were again centrifuged and the sup¬ 
ernatants removed. The cell buttons were each gently mixed 
over ice with 3 ml sterile distilled water for 20 sec, to lyse 
the red cells, and then mixed with 1 ml 3.6% NaCl to restore 
isotonicity. The cells were washed once more in buffer, resuspended 
in a small volume of buffer, counted with a Coulter particle 
counter, and adjusted to the desired concentration. Wright-stained 
slides were prepared for differential leukocyte counts of all cell 
isolates; it was found that regularly 60-75% of the leukocytes 
were neutrophils. 
Heat-killed Bacteria: 
Cultures of Staphylococcus albus were stored on blood 
agar plates at 4 C and passed to new plates every three weeks. 
For the experiments, the bacteria were cultured for 18 hrs in 
beef-heart infusion broth, centrifuged, washed once in normal 
saline, and then suspended in a small volume of saline. The 
concentration of bacteria was estimated from a constructed curve 
of transmittance at 600 mu and confirmed by quantitative plating 
in agar. The bacteria were killed by autoclaving at 15 lbs pres¬ 
sure for 20 min. Aliqots of 4-5 ml were frozen and stored at -20°C. 
"this buffer was sterilized by autoclaving for 2 hrs the individual 
constituent solutions which were: Krebs-Ringer base (100 parts 
.9% NaCl, 4 parts 1,15% KC1, 0,6 parts 1.22% CaCl2, 0.2 parts 
3,82% MgSO^) and phosphate buffer (14.3 gm N^HPO^ in distilled (cont,) 
a strain originally obtained from a finger abscess 
. ' 
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Incubation of Leukocytes: 
1.0 ml of leukocyte suspension (containing 2,6-3,4 x 10 
leukocytes/ml) were incubated in 25 ml flasks with 1,5 ml buffer, 
0,3 ml autologous serum from the blood donor, and 0,2 ml saline 
or bacteria suspension, for 1 hr at 37.5°C in a shaking water 
bath, 25 ml Erlenmeyer flasks with 2,7 ml buffer and 0,3 ml 
serum were also prepared and incubated concurrently. In each 
experiment flasks containing leukocytes with or without bacteria 
were incubated in duplicate; in each experiment phagocytizing 
leukocytes and control leukocytes without bacteria were prepared 
at the same time from the same blood donor and were incubated 
concurrently. 
Preparation of Leukocytes for Morphology’14^ 
Drops of cell suspensions after incubation were 
placed on sterile slides, then covered with sterile coverslips. 
After incubating the slides for 20 min at 37°C in covered petri 
dishes containing a moist filter paper, the coverslips were re¬ 
moved, quickly air dried, then stained with Wright’s stain. 
Preparation of Cell Fractions: 
After incubation, leukocyte suspensions were centri¬ 
fuged in 12 ml tubes at 1200 rpm (International Centrifuge) for 
10 min at 4°c, The supernatants represented the "extra-cellular 
water, adjusted to pH 7.4 with 16(1) ml of 1 N HC1, and made up 
to 1000 ml.') For each experiment 10 mg/100 ml heparin was added 
to the final K-R buffer solution which consisted of 105 parts 
Krebs-Ringer base and 20 parts Phosphate buffer. 
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media fractions." The cell buttons were either resuspended in 
0,2 M sucrose up to 3.0 ml, representing the "whole cell frac¬ 
tions," or they were resuspended for preparation of "nuclear," 
"granular," or "soluble" cell fractions. The preparation of these 
latter three cell fractions was done according to a previously 
53 
reported method. By this method the cell buttons, having been sep¬ 
arated from the media, were resuspended in 5.5 ml of 0,2 M 
sucrose; 0,3 ml heparin (5000 U/ml) was added to the cell suspen¬ 
sions and gently mixed with a pasteur pipette until marked viscos¬ 
ity appeared^ indicating cell lysis. The lysate suspensions were 
then centrifuged at 1200 rpm (International Centrifuge) for 10 
o f 
min at 4 C; the su-spernatants were transferred to high speed 
Sorvall tubes and centrifuged at 10,000 rpm (12,000 g, Sorvall 
Centrifuge Superspeed SS-3) for 20 min, while the buttons were 
resuspended to 3 ml in 0.2 M sucrose and saved as the "granular" 
fractions. All fractions were frozen and stored at -20°C not more 
than three days until enzyme determinations could be made. 
When enzyme activities were measured, the values obtained for the 
"soluble" fractions were multiplied by a factor of 2 in order 
to adjust for differences in dilution. 
Determination of Lysozyme: 
The assay for lysozyme activity used in these ex¬ 
periments is an adaptation of a commonly used turbidometric 
54 
method," 3,0 ml aliquots of substrate solution were warmed to 
80 mg of a standard M. lysodeikticus cell wall preparation, 
Bacto-Lysozyme Substrate, Difco laboratories, Detroit, Mich., (cont, next pg) 
^"buttons from this centrifugation were resuspended to 3 ml in 0.2 M 
sucrose and saved as the "nuclear" fractions. 
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37°C. 0.5 ml of sample to be measured was then added to an 
aliquot of the substrate suspension, mixed, and transferred to 
a spectrophotometer cell which had also been warmed to 37°C. 
Lysozyme activity, or lysis of the cell walls in suspension, was 
represented by change in optical density at 540 mu over timej 
enzyme activity was expressed in terms of ugms. of egg-white 
lysozyme”' and in terms of ugms. of purified human lysozyme isol¬ 
ated from leukemics* urine, according to standard curves prepared 
at the time of the enzyme assays,^ Before enzyme determinations 
were made, all fractions were freeze-thawed 5 times with 0.1 ml 
of 1.0% Triton-X 100, a neutral detergent. 
Determination of Lactic Dehydrogenase: 
Leukocyte LDH determination was measured by an accepted 
55 
method for serm LDH determination, ^ 0,1 ml of the sample to be 
measured was mixed with 2.85 ml of Pyruvate solution (0.05 M phos¬ 
phate buffer at pH 7.5, 3.1 x 10~^ Pyruvate) and 0.05 ml DPNH 
-3 
solution (8 x 10 M B-DPNH in Pyruvate solution). Change in 
optical density at 340 mu, which occurred with oxidation of 
DPNH, was recorded with a spectrophotometer equipped with a re¬ 
corder ; temperature of the reaction was controlled at 25°C. 
LDH activity was expressed in Uroblewski units. ~ 
suspended in 50 ml of buffer at pH 6.2, Bacto-Lysozyme Buffer, 
Difco. Labs., and homogenized with a teflon pestle for 2 min. 
Hitachi Perkin-Elmer Spectrophotometer #139, equipped with a 
Sargent Recorder SRL 
Bact-Lysozyme, Difco Labs, 
Human Lysozyme, courtesy of Dr. Stuart Finch 
Rohm and Haas Co,, Phil,,Pa, 
t measurements of lysozyme and LDH in the "media”' fractions were 
always adjusted for enzyme activities in the serum which made up a 
portion of the incubation media. 
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esults 
The localization of lysozyme activity in the extra¬ 
cellular media and in the various cell compartments, when leuk¬ 
ocytes have been incubated for 1 hr with and without bacteria, is 
illustrated in Fig. 1. Active phagocytosis with most neutrophils 
ingesting more than 5 bacteria was demonstrable microscopically 
for the leukocyte cultures incubated with bacteria (at a mult¬ 
iplicity of 10-20 bacteria to I neutrophil). Only neutrophils 
and monocytes (the latter cell type representing no more than 5-8% 
of the isolated leukocytes) were observed to ingest bacteria. 
In Fig, 1 it is evident that the greatest changes in distribution 
of lysozyme which occur with phagocytosis are in the "granular” 
and in the "medium" fractions, indicating a release of lysozyme 
into the incubation media during phagocytosis. A negligible 
increase of lysozyme activity was observed in the "soluble" or 
cytoplasmic fraction -- a finding which differs from observations 
made with other granular enzymes in rabbit neutrophils,14'1' This 
finding, however, agrees with observations of others with acid 
and alkaline phosphatase, B-glucuronidase, and peroxidase in 
human leukocytes, 1 
The decrease in lysozyme activity that occurs in the 
"nuclear" fraction with phagocytosis may be considered to re¬ 
present for the most part a decrease in the granule bound fraction, 
for the "nuclear" fraction was found microscopically to contain 
a proportion of whole leukocytes which had not been lysed in 
the fractionation procedure, as well as a proportion of adherent 
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granules j this finding corresponds to the experience of others 
27 53 in preparing leukocyte fractions. * 
In these experiments, as the media enzyme activity is 
found to increase after phagocytosis, the total cellular enzyme 
is found to decrease. Also of note is the fact that the total 
enzyme (cellular + media enzyme) recovered from the cultures in 
which phagocytosis occurs is less than that recovered from control 
t 
cultures. 
The kinetics of the shift of lysozyme activity from 
the cells to the extra-cellular incubation media during phag¬ 
ocytosis were investigated with varying degrees of phagocytic 
challenge (multiplicity of bacteria/ neutrophil) and with vary¬ 
ing incubation times. The results of these experiments are pre¬ 
sented in Figs, 2 and 3. It is evident in Fig, 2 that the extra¬ 
cellular release of lysozyme increases x^ith the phagocytic chal¬ 
lenge up to a certain point (about 30 to 1, bacteria to neutrophils) 
at which multiplicity the release of enzyme appears to remain 
fairly constant; this finding is perhaps best explained by the 
supposition either that the leukocytes become saturated with 
ingested bacteria at a high multiplicity or that the mechanism 
by which enzyme is released from the cells has a limit, When the 
leukocytes are incubated at a high multiplicity (Fig, 3), it is 
evident that most of the extra-cellular release of lysozyme occurs 
during the first 30 min of incubation, by xvdiich time most of the 
27 
phagocytosis is knoxm to have occurred. The data of Fig, 3 
+in Fig. 1 total enzyme activity recovered from the M,N,G, and S 
fractions of phagocytizing cells is °0% of that recovered from 
combined fractions of control cells. 
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correspond to previously reported findings which related the 
appearance of granular enzyme extra-cellularly to time of phag¬ 
ocytosis,' ' The values for total leukocyte lysozyme, which 
were found to vary with different leukocyte isolations and 
with different blood donors, agree with absolute values of lysozyme 
activity recovered from leukocytes reported by others (12.0 - 22.0 
ugms egg-white lysozyme/ 10 WBC’s isolated from five normal 
controls). ' 
Since it was important to know if the extra-cellular 
release of lysozyme, which was observed to occur with phagocytosis, 
represents injury to neutrophils, phagocytosis experiemnts were 
performed in which both lysozyme and lactic dehydrogenase, a non¬ 
granule bound enzyme located in the cytoplasm, were measured 
concurrently. The results are presented in Fig. 4. These exper¬ 
iments demonstrate that, while lysozyme is released from the 
leukocytes, coincidental release of IDH does not occur. These 
results confirm findings of others who compared the fate of non- 
granular and granule bound enzymes in a similar experimental 
system. These results also support the conclusion that mobilization 
of granular enzymes during phagocytosis is not accompanied by 
decreased viability of the leukocytes; studies with similar exper¬ 
imental systems have demonstrated, by dye exclusion techniques, 
no loss of viability of neutrophils as a consequence of phagocyto- 
sis.49-51 
Discussion 
It would be dangerous to assume that the release of 
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lysozyme with phagocytosis is a model for the behavior of other 
enzymes associated with neutrophil granules. In fact, there is 
evidence that lysozyme may be differentiated from other granular 
enzymes, at least in rabbit neutrophils, according to the extent 
to which it is associated with the granular fraction (about 50%, 
compared with 60-70% for other enzymes, eg, acid phosphatase and 
„ 27 
B-glucuronidase), and according to the specific granules with 
57 58 
which lysozyme is associated," In studies of rabbit neutro- 
phil granules, investigated by/\gradient centrifugation, lysozyme 
activity was found to be associated with two types of granules -- 
small sized granules where most other granular enzymes are located^ 
and somewhat larger granules in which alkaline phosphatase was 
S7JS6 
also found. These studies suggest that human neutrophils, also, 
may contain divers granule types. Therefore, one must be cautious 
in draxtfing conclusions about neutrophil granular enzymes in gen¬ 
eral from studies of lysozyme alone. 
On the other hand, the results of these experiments 
with human leukocytes, demonstrating the shift of lysozyme activity 
from the granules to the extra-cellular media, correspond very 
closely to previously reported experiments that demonstrate a 
shift of B-glucuronidase from the "granular” to the extra-cellular 
/ /r 
fractions when human leukocytes ohagocytize starch particles,"'’ 
In another study the peroxidase of human neutrophils was found 
48 
to behave similarly with phagocytosis. 
The loss of acid phosphatase activity from human 
leukocytes when these cells phagocytize particles has been re¬ 
ported by several investigators;^’ ^ their results correspond 

to the findings of the present experiments and clearly differ 
from results of earlier studies with rabbit neutrophils, in 
f ry 
which ho loss of granular enzymes were found after phagocytosis. “ 
Even with rabbit neutrophils, however, several more recent stud¬ 
ies have demonstrated a release of granule associated enzymes 
comparable to the results presented here with human leukocytes.^’ 
A net loss of enzyme activity (incubation media enzyme + 
cellular enzyme) noted in these experiments, when leukocytes 
were challenged with a high multiplicity of bacteria to be in¬ 
gested, has not been reposed by other investigators. Despite 
trying different methods of releasing the lysozyme activity 
from the various fractions (eg, sonication, increased freeze¬ 
thawing), I was unable to alter this result. 
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III. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYLATE 
UPON THE EXTRA-CELLULAR RELEASE OF LYSOZYME FROM LEUKOCYTES 
It has been proposed that various anti-inflammatory 
drugs work in part by virtue of an effect upon the mobilization 
of the granular enzymes contained in neutrophils.'Evidence for 
this have been provided by a variety of studies which have demon¬ 
strated that divers anti-inflammatory drugs protect _in_ vitro 
suspensions of lysosomes (derived from rat liver cells) against 
spontaneous or induced disruption which would otherwise release 
the activity of their bound enzymes. '' .reviews) Glucocort¬ 
icoids, GOich£cjne f 62 ancj aCetyl sal icy lie acid^ have 
each been reported as having a "stabilizing” effect upon rat 
liver cell lysosomes, although certain investigators have refuted 
these findings with cochicine^®*^ and salicylate^ Colchicine 
has, however,been shown to inhibit the degranulation of the in¬ 
tact, phagocytizing neutrophil, and it has been suggested that 
this drug inhibits intracellular mechanisms by which the granules 
fuse with phagocytic vacuoles containing ingested particles.*1' ’ 
The proposals that these anti-inflammatory drugs have 
a pharmacological action by virtue of an effect upon the re¬ 
lease of granular enzymes within the phagocytizing leukocyte, 
have assumed that these digestive enzymes are also released in 
active form, to some extent, outside the cells and thereby be¬ 
come available for tissue damage at the site of neutrophil infil¬ 
tration. The experiments with lysozyme presented above, and recent 
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studies by others with lysozyme and other granule associated 
enzymes, provide direct evidence that granular enzymes do es¬ 
cape from neutrophils, particularly when these cells phagocytize 
large numbers of particles. 
The following experiments demonstrate that while 
colchicine and cortisol inhibit the release of lysozyme from 
phagocytizing leukocytes,salicylate does not have this effect. 
Methods 
Phagocytosis by Drug Treated Leukocytes: 
For each experiment sufficient donor blood was drawn 
in order to provide leukocyte isolates (as described) for 16 
leukocyte cultures. In the experiments each culture flask con¬ 
tained 2,9 - 3,1 x 10^ leukocytes in serum buffer media as des¬ 
cribed; each flask was preincubated with or without drug for 
30 min after which the leukocyte cultures were incubated with 
or without heat-killed Staphylococci (at adjusted concentrations 
such that the multiplicity of bacteria to neutrophils was 30 to 1) 
for an additional 60 min; each culture contained a final vol¬ 
ume of 3.0 ml The following experimental alternatives were 
prepared and incubated concurrently and in duplicate: 
1. Leukocytes + serum-buffer media 
2. leukocytes + media + bacteria 
3. Leukocytes + media with Colchicine (2.5xlO“3M) 
4. Leukocytes + media with Colchicine + bacteria 
5. Leukocytes + media with Na Salicylate 
(2.2x10”3M) 
Colchicine: U.S.P., Sigma Chem, Corp., St, Louis, Mo, 
' Na Salicylate: U.S.P., Mallinckrodt Chem,, St, Louis, Mo. 
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6. leukocytes + media with Na Salicylate 
+ bacteria 
7. leukocytes + media with Cortisol (5xlO"“'M) 
8. leukocytes + media with Cortisol + bacteria 
In each experiment the various cultures were incubated 
at the same time, with leukocytes prepared from the sane blood 
donor (although different donors were used from experiment to 
experiment) in order that the comparison among drug and control 
groups would be the more meaningful by adjusting for variations 
in the experimental system, eg, numbers of leukocytes, mult¬ 
iplicity of bacteria (an effort was made to keep these num¬ 
bers as constant as possible), and different blood donors. 
After incubation, cells were separated from their media, 
and the the cellular and media lysozyme activity was measured as 
previously described. None of the drugs at the concentrations 
used had a demonstrable effect upon the assay for lysozyme. 
Several separate experiments were done in which control 
cultures were compared with cultures to which acetylsalicylic 
** 
acid (10 M) was added, both groups incubated as described 
above, with and without bacteria. 
Separate experiments were also done in which isolated 
human neutrophil granules (prepared as described for the "granular 
fraction") suspended in 3.0 ml K-R phosphate buffer, with or without 
10"^M acetylsalicylic acid, were incubated at 37.5°C for varying 
periods of time (0 min, 60 min, and 180 min). After incubation 
'"Cortisols Hydrocortisone Sodium Succunate (Solu-Cortef) , Upjohn, 
Kalamazoo, Mich. 
‘“Acetylsalicylic Acid: U.S.P, Merck and Co., West Point, Pa. 
. 
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the granule suspensions were centrifuged at 10,000 rpm for 
20 min (Sorvall centrifuge). The supernatants and the pellets, 
which were resuspended in an equal volume (up to 3.0 ml) in 0,2 M 
sucrose and were then freeze-thawed x 5, were both measured 
for lysozyme activity. (Note: The concentration of acetylsalicylic 
acid (10”^m or IS mg%) used in these separate experiments, lower 
than that used for rva salicylate, was necessitated by the rel¬ 
ative insolubility of ASA.) 
Results 
There was some variation from experiment to experiment 
in the percentage of total enzyme activity lost from the leuk¬ 
ocytes during phagocytosis (32 - 60%) and in the percentage of 
total enzyme activity gained in the extra-cellular media (15 - 33%). 
However, within individual experiments, colchicine and cortisol in¬ 
hibited the release of lysozyme from the leukocytes into the 
media, whereas salicylate did not have this effect. These exper¬ 
iments are summarized in Fig.5; since the drug treated cultures 
without bacteria showed no significant differences from the control 
cultures without bacteria, these values are not included in Fig.5, 
The mean differences between the control and drug treated ex¬ 
perimental groups are given in Table lj the differences between 
control extra-cellular media and the media from drug treated 
cultures, as well as the differences between control cell lysozyme 
and drug treated cell lysozyme, are statistically significant 
for the colchicine and cortisol groups. 
"by paired t-test 
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TA31E 1. 
Differences in lysozyme Distribution 
bet\:*~ n D-'- Tr>: -tr-,! o C-. ntml C11 s 
>'ean 
Differenccs 
+ 2^: 
Cellular 
Enzyme after 
Fharocytosis 
C<~ 1 cb i ■: 
13 r.(+i. *)* 
p < . oooI 
‘ E.? : i cc T .i te 
-3.5:;(t2.2) 
p> .lO'MS 
Cor’:'; il 
n.2%(+i.?) 
p< . OOOl 
(10 experiments) 
Mean 
-10Z(+2.2) 2.or(il.7) -7.37(11,7) 
p< .oooS- p>.IOiA/S p< ,ooi 
(10 experiments) 
"Values expressed in 7. of total 1 ysozyme 
Slides were prepared for morphology from all leukocyte 
cultures after incubation,* all drug treated samples showed active 
phagocytosis by neutrophils which had been exposed to bacteria. 
Photomicrographs of representative neutrophils containing in¬ 
gested Staphylococci are presentedin Fig. 6, None of the drugs 
appeared to prevent or inhibit phagocytosis at the concentrations 
of drugs used. In Fig. 2 there is further evidence that differ¬ 
ences in ingestion did not produce the differences observed in 
enzyme activity release; for this to be the case, drug treated 
cells would have had to have ingested only one half as many 
bacteria as control cells -- clearly not the case. 
Separate experiments comparing control cells with 
-3 
cells treated with acetylsalicylic acid (10 or 18 mg%) ailed 
to show an effect by this drug upon the release of lysozyme 
during phagocytosis (Fig, 7). In two experiments this drug 
also failed to "stabilize” isolated granules against spontaneous 
disruption when granule suspensions were incubated in the 
presence of the drug, (Fig, 8). 
Discussion 
Although both colchicine and cortisol prevent the 
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FIG. 6 
NEUTROPHILS 
WITH PHAGOCYTIZED 
STAPYLOCOCCI 
Control 
Cells 
Colchicine 
Treated 
Cells 
Salicylate 
Treated 
Cells 
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release of lysozyme from phagocytizing leukocytes, as one would 
predict from the demonstrated effects of these drugs in other 
systems (inhibition of degranulation or "stabilization" of iso¬ 
lated lysosomes against disruption), salicylate was not found fo 
have this effect. It may be that the concentration; of salicylate 
used, or the time of pre-incubation of the leukocytes with drug 
before they were challenged with bacteria, were inappropriate 
for producing an effect in this experimental system. However, 
-3 
the concentrations of salicylate used, 1-2,2 x 10 M, represent 
the upper limit of a pharmacologic plasma level (18 - 35 mg%) 
and were larger than concentrations of salicCylate previously 
reported to have an effect of "stabilizing" lysosomes of rat 
-5 liver cells (concentrations as low as 10” M acetylsalicylic 
63 
acid were reported to have this effect). In several experiments 
in which I attempted to "stabilize" neutrophil granules against 
disruption, no effect of salicylate was found. Experiments 
presented here, in sum, refute the proposal that salicylate owes 
part of its anti-inflammatory action to an effect upon the mobiliz¬ 
ation of granular'enzymes in inflammatory leukocytes. 
On the other hand these experiments lend further 
support for the hypothesis that granular enzymes are mobilized 
by neutrophils during phagocytosis and are released in part into 
the extra-cellular spaces, particularly with active phagocytosis. 
Inhibition of this process by colchicine and cortisol may ac¬ 
count, in part, for their anti-inflammatory actions in vivo. 
It is important to note that the concentrations of 

-34- 
colchicine used in these experiments ( and in similar ex¬ 
periments reported by others) are much, higher than plasma 
levels of drug that are apparently achieved _in vivo with 
normal therapeutic doses (as much as 1000 times as high by one 
report).^"1 Because of this discrepancy between _in vitro and in 
vivo drug levels, it has been suggested that among the numerous 
effects of colchicine upon divers stages of the inflammatory 
process only those effects which can be demonstrated at concen¬ 
trations of drug jin vitro comparable to measured plasma levels 
* 6 6 
may be considered to be important effects pharmacologically. 
Inhibition of neutrophil chemotaxis is one effect reported to 
occur at such concentrations of drug j_n vitro. 
Certainly this is an important consideration. However, 
it would be erroneous to assume that the concentrations of 
drug to which neutrophils are exposed in these experiments may 
be equated entirely or even in part to in vivo plasma levels; 
plasma levels by themselves do not indicate intracellular con¬ 
centrations of drug, nor do they account for time of exposure. 
In these experiments drug effects are demonstrated after only 
60 - 00 min exposure of neutrophils to drug, whereas the anti¬ 
inflammatory effects of colchicine > are observed and 
measured over much longer periods of time. Furthermore, since 
colchicine appears to have a series of effects upon neutrophils, 
it is to be expected that much lower concentrations may be re- 
"Plasma levels of colchicine after therapeutic doses have been 
reported to range between 1 and 3 ugms/100 ml; drug concentration 
used in these experiments is lOugm/ml. 
- 
-35- 
quired to show an anti-inflammatory effect _rn vivo than are 
required to demonstrate a single effect in an _in vitro ex¬ 
perimental model, 
A similar discussion is appropriate concerning the 
concentrations of Cortisol used in these experiments. In studies 
which measured plasma cortisol levels achieved in normal volunteers 
after oral doses of 200 mg Hydrocortisone Acetate, maximum levels 
67 
of 125-ugm/ml were found. This compares with a concentration of 
18 mg/100 ml of cortisol used in these experiments -- a concentration 
about 150 times as high as the jm vivo plasma levels. Since ther¬ 
apeutic doses as high as 400 mg of oral hydrocortisone are some¬ 
times used to suppress inflammatory diseases, and since cortisol 
levels achieved in inflammed tissues are known to be higher than 
68 
in normal tissues, one may argue that the jin vitro levels of 
drug used in these experiments are more in the range of 50 times 
as high as the reported therapeutic plasma levels of cortisol.in 
However, as with colchicine, it would be erroneous to equate 
measured cortisol plasma levels with concentrations of drug found 
to have an effect _i_n vitro, for there are obvious differences in 
exposure times, cells to drug. Also, as mentioned before, plasma 
levels ^in vivo, by themselves, do not indicate cellular concen¬ 
trations of drug. Furthermore, glucocorticoids, like colchicine, 
have been shown to have effects upon several stages of the inflam- 
& 
matory process, and, as mentioned before, it would not be unex¬ 
pected that one effect _in vitro would require a larger concentration 
of drug than would the sum of several effects in vivo. 

IV. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYLATE 
UPON THE MOBILIZATION AND RELEASE OF LEUKOCYTE ACID PHOSPHATASE 
AND CATHEPSIN 
As has been discussed, it would be dangerous to assume 
that all enzymes bound in neutrophil granules behave as does 
lysozyme. Therefore, two other granular enzymes -- acid phos¬ 
phatase and cathepsin (acid protease) -- were studied in the same 
experimental system that has been presented. Both of these 
enzymes, as studied by others, have been reported to be released 
47,#,49 
from neutrophils during phagocytosis. 
Methods 
The glassware, solutions, buffer, isolation and in¬ 
cubation of leukocytes with and without bacteria, with and with¬ 
out drugs, as well as the preparation of cellular and extra¬ 
cellular media fractions for enzyme determinations, were as 
previously described. 
Measurement of Acid Phosphatase: 
An assay for acid phaosphatase which uses a-naphthyl 
69 
acid phosphate as a substrate was chosen for several reasons. 
First, since I wished to measure enzyme activity in an incubation 
media made up largely of phosphate buffer, it was necessary to use 
an assay which did not depend upon the measurement of free phos¬ 
phate split off from a substrate. Second, this assay proved itself 
to be, as others found it, very sensitive and reproducible. 
Third, in rabbit neutrophils there are at least two acid phospha- 
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tases with different substrate specificities: the assay that 
uses p-nitrophenyl phosphate as a substrate measures enzyme activ¬ 
ity which for the most part is not located in the granular frac¬ 
tions as are other lysosomal enzymes, whereas an assay using B-gly- 
cerophosphate as substrate measures enzyme activity located 
57 5B 
almost exclusively in the small neutrophil granules." ’ The 
assay chosen for these experiments, a fluormetric method, has been 
observed to have the same substrate specificity as the latter 
7n 
substrate and to be more sensitive. 
0,1. ml of sample to be measured was mixed with 1,0 ml 
of 0.1 M acetate buffer at pH 6,1 and with 1.0 ml buffer which 
contained a concentration of 5 mM a-naphthyl phosphate sodium" 
(or 60 mg/50 ml). Each individual sample was measured in dupli¬ 
cate, together with a blank, consisting of 0.1 ml sample and 
2,0 ml buffer; sample blanks were measured in each case in order 
to correct for background fluorescence of the sample itself. 
The acetate buffer was made up before the assay procedures and 
stored at 4°C; the substrate-buffer solution was prepared 
fresh with each set of assay measurements. The sample-substrate- 
buffer mixtures were incubated at 37°C in a shaking water bath 
for 15 min, after which 1,0 ml of 0.5 N NaOH was added and 
the mixture immediately measured for fluorescence in a FOCI 
Spectrophotometer Mark I, Ferrand Optical Co/' Acid phosphatase 
Mann Research Labs, N,Y.,N.Y. 
'Incident wave length, 340 mu, emitted wave length, 455 mu, optimal 
for measuring fluorescence of free a-naphthol which is the 
reaction product promoted by enzyme activity. 

-38- 
activity is expressed as uM/ml free a-naphthol/ 15 min, corrected 
for sample blank measurements. Colchicine and cortisol were not 
found to interfere with the assay; salicylate did, however, cause 
an interference which is discussed below. 
Measurement of Cathepsin: 
The assay for cathepsin used in these studies has been 
27 
used commonly in studies of leukocyte granular enzymes. It 
.7? 
measures proteolysis of denatured hemoglobin at pH 3,/, 0,5 ml 
of sample to be measured was added to 0.5 ml distilled water 
and 1.0 ml substrate solution. Each sample was measured in dup¬ 
licate, Control blanks of 1,0 ml distilled 
water and 1.0 ml substrate solution were also prepared. Samples 
with serum-buffer alone or with each of the three drugs in the 
experimental concentrations were also measured in order to adjust 
for serum enzyme or for drug interference. As with the assay for 
acid phosphatase, only salicylate was found to interfere with the 
assay (discussed below). All sample-substrate mixtures were in¬ 
cubated in a water bath at 37°C for 2 hrs,'after which 2,0 ml 
of a 5% TCA solution was added to stop the reaction, precipi¬ 
tating undigested hemoglobin protein. The assay mixtures were 
incubated at 37JC for an additional 1 hr and were then centri¬ 
fuged at 1500 rpm (International centrifuge) for 10 min. The 
'2,2% denatured hemoglobin (Hemoglobin Substrate, Mann Research 
Labs., N.Y.) in 0,05 M acetate buffer at pH 3.7 
r, ’ 
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supernatants were pipetted into new tubes and stored over night 
at 4°C, The supernatants were then measured for free peptides by 
72 
the Lowry method 0,4 ml of supernatant sample was mixed with 
2,0 ml "reagent I" and allowed to stand for 10 min, then 0,2 ml 
"reagent II" was added and mixed rapidly. After the mixtures had 
been allowed to stand for an additional 30 min, they were read in 
a spectrophotometer at 750 mu for optical density. Results 
were translated into ugm protein/ml/ 2 hrs, from a standard 
curve prepared concurrently from protein solutions (bovine albumin) 
of known concentration. Results were corrected for assay blank 
values. 
Effects of the Drugs upon the Enzyme Assays: 
None of the drugs affected the total cellular enzyme ac¬ 
tivities recovered from control leukocytes without bacteria. 
Neither colchicine nor cortisol affected the assays for enzyme 
activities■in the incubation media. Salicylate, however, in¬ 
terfered with both assays for incubation media enzyme activities. 
Salicylate had an intrinsic fluorescence at the wave lengths used 
in the acid phosphatase assay, but it was possible to adjust for 
this extra fluorescence by subtracting sample blank values (de¬ 
scribed above). Similarly, Salicylate interfered with the 
cathepsin assay by causing a color reaction by itself in the 
100 parts 3% sodium, carbonate in 0,1 N NaOH, 1 part 4% sodium 
potassium tartrate, 1 part 2% copper sulphate, 
a 1:2 dilution of 2 K Phenol reagent, Fischer Scientific. 
Hitachi Perkin-Elmer #139 

Lowry reagents -- this interference was adjusted for by subtracting 
salicylate-media blank measurements from sample measurements. 
Results 
As was demonstrated with lysozyme, phagocytosis of 
bacteria by neutrophils is accompanied by a loss of acid phos¬ 
phatase and cathepsin activity from the cells and an increase in 
the activities of these enzymes recovered from the incubation 
media (Fig.0), However, the percentages of total enzyme activities 
recovered from the extra-cellular media fractions are much 
smaller than those observed in measurements of lysozyme, and 
the differences of these enzyme activities in the incubation med¬ 
ia of phagocytizing leukocytes from the enzyme activities in 
the media of non-phagocytizing cells xi?ere much too small to 
demonstrate significant drug effects. On the other hand differences 
among enzyme activities recovered from the cell fractions were 
quite sufficient to demonstrate significant drug effects (Fig. 10 
and Table 2), As in experiments with lysozyme, colchicine and 
Cortisol consistently inhibited the loss of enzyme activities 
from the leukocytes during phagocytosis, whereas salicylate did 
not have this effect. The differences between the experimental 
groups and the controls were consistently reproduced from ex¬ 
periment to experiment and are statistically significant. 
It was thought possible that smaller percentages of 
acid phosphatase and cathepsin were recovered in the extra-cell¬ 
ular incubation media, than percentages of lysozyme, because of 
*>v 
by paired t-test 
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TABLE 2. 
Differences in Cellular Acid Phosphatase and 
Cathepsin between Control and Drop Treated Cells 
Colchicine 
Kean 
Differences 13.3%(i2.4) 
i SEK, Cellular j><.ooi 
Acid Phosphatase n = 3 
after Phagocytosis 
Na Salicylate 
-1,3%(ll.4) 
•p > . 2o , NS 
n = 7 
Cortisol 
13.07%-2.9) 
p < .oor 
n = 6 
Kean 
Differences 
t SEK, Cellular 
Cathepsin after 
Phagocytosis 
7.l%(tl,4) 
p K. • o o l 
n = 3 
-1.9%(tl.4) 
p > . lo , US 
n = 7 
3.3%(+2.0) 
p < -oof 
n 53 6 
Values expressed in 7 of total enzyme 
recovered from non-phagocytizing control cells 
differences in the stabilities of these enzymes in the exper¬ 
imental system. To test this hypothesis, two supplementary 
experiments were done. In the first of these experiments leuk¬ 
ocyte lysates were incubated for varying periods of time in the 
serum-buffer media. Leukocyte suspensions were freeze-thawed in the 
presence of 0.1% Triton-X 100 to lyse the cells and release the 
granular enzymes into solution; aliquots of lysate in serum- 
buffer media were then measured immediately for enzyme activity 
or were incubated for 30 to 60 min to see if enzyme activities 
o 
decreased during this time of incubation at 37.5 C. Representative 
results from these experiments are indicated in the left-hand 
half of Fig. 11. Acid phosphatase and cathepsin clearly demon¬ 
strate different stability characteristics than does lysozyme, the 
first two enzymes losing 50 - 60% of their activity in 60 min, 
while lysozyme loses no more than 8% of its activity during this 
time. 
Since this experiment compared the behavior of enzymes 
contained in a crude cell soup and not of enzymes which had been 
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released exra-cellularly by intact leukocytes, according to the 
process describ-ed by previous experiments, a second group of 
supplementary experiments was done. Since it was known that 
some increased acid phosphatase and cathepsin activity was re¬ 
covered from the extra-cellular media of phagocytizing leukocytes, 
(although this increased activity was small) large numbers of 
leukocytes (3-5xl0^/ml) were incubated with bacteria at a 
multiplicity of about 30:1 for 30 min (sufficient time for most 
of the enzyme release to occur according to Fig, 3)^ with the in¬ 
tention of causing a large release of enzyme during phagocytosis. 
After the incubation, the cells were separated from the media by 
centrifugation, and aliquots of media were either measured im¬ 
mediately for enzyme activity or were incubated for varying addit¬ 
ional periods of time before enzyme activities were measured. Re¬ 
presentative results are presented in the right-hand half of Fig. 11. 
The lysozyme released extra-cellularly from leukocytes loses 
little activity with further incubation, whereas the acid phos¬ 
phatase and cathepsin released from the cells are clearly un¬ 
stable . 
Discussion 
As is the case with lysozyme, human leukocytes also lose 
acid phosphatase and cathepsin, other granule associated enzymes, 
during phagocytosis. In addition, as was shown with lysozyme, 
colchicine and cortisol inhibit the loss of these granular 
enzymes from the leukocytes, while salicylate fails to have this 
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effect, The inhibition by colchicine of the loss of acid phos¬ 
phatase from phagocytizing leukocytes confirms previously pub¬ 
lished data, in which a different assay for acid phosphatase 
40 
was used. Measurements of enzyme activities in the extra-cell¬ 
ular incubation media did not reproduce the results obtained when 
lysozyme was measured; although consistent increases in acid phos¬ 
phatase and cathepsin activities x^ere observed with phagocytosis, 
these increases xrere small and differences x?ere too small to 
demonstrate significant drug effects. These txro enzymes, hox<rever, 
when incubated free in culture media, proved to be much less stable 
than lysozyme, and it seems likely that acid phosphatase and 
cathepsin are released from the phagocytizing neutrophils as 
is lysozyme, but are not recoverable in convincing amounts be¬ 
cause of their relative instability during the 60 min period of 
incubation. It is also possible, of course, that some of these 
enzymes are degraded within the cells and are not released 
extra-cellularly, 
The question of enzyme stabilities has not been re¬ 
ported as important in other studies of this kind. In the present 
studies, however, phagocytosis clearly is accompanied by de¬ 
creases in total measureable enzyme for all three granular enzymes 
investigated. In one reported study, x/hich compared phagocytosis 
by normal human leukocytes x-rith phagocytosis by leukocytes from 
patients with Chronic Granulomatous Disease, a decrease in 
total acid phosphatase activity i*ecoverable after phagocytosis 
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was observed with the normal cells; furthermore, this decrease 
in total enzyme activity was not reproducible with rabbit neutro¬ 
phils. These investigators, however, did not attempt to explain 
their observations by studying enzyme stabilities in their ex- 
59 
penmental system. 
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V. THE EFFECTS OF COLCHICINE, CORTISOL, AND SALICYATE 
UPON THE EXTRA-CELLULAR RELEASE OF LEUKOCYTE "NEUTRAL" 
PHOSPHATASE 
Because it was apparent that the release of acid phos¬ 
phatase from phagocytizing leukocytes may be masked by the in¬ 
stability of this enzyme when freed into the medium, several 
experiemnts were done in which phosphatase substrate was added 
to the incubation media. By this maneuver, enzyme released 
from the leukocytes could act upon the substrate immediately, 
thus "trapping" the enzyme activity before degradation of the 
enzyme could occur. For these experiments it was assumed that 
the phosphatase-associated reaction occurred at pH 7.4, the pH 
of the serum-buffer media; therefore, the enzyme activity measured 
in these experiments is referred to as "neutral" phosphatase. 
The effects of Colchicine, cortisol, and salicylate were compared 
under these new experimental- conditions. 
Methods 
The preparation and incubation of leukocytes with 
bacteria was as previously described. Drug-treated leukocyte 
cultures were also prepared as described; however, a-naphthyl 
phosphate substrate was added to the serum-buffer media such that 
the leukocytes were incubated with substrate at a concentration 
of 1.75 mg/ml. It was calculated that this addition ofsubstrate 
(a sodium salt) added approximately 28 mOsm to the osmolarity of 
the incubation media (fromw308 to 336 mOsm). The incubation 
of leukocytes with enzyme substrate is not without precedent; 
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a study of the 1950*s used an experimental system whereby leuk¬ 
ocytes were incubated in the presence of lysozyme substrate in 
order to quantify leukocyte damage secondary to various insults 
(eg, hypotonicity of the extra-cellu.lar medium, endotoxins) -- 
lysis of the substrate was taken as evidence of leukocyte dam- 
17? 
age with extrusion of leukocyte enzymes. 
After the leukocyte cultures were incubated with or 
without bacteria, x^ith or without drug, the cells were removed 
by centrifugation. The extra-cellular media fractions were then 
made strongly alkaline with the addition of 2,0 ml of 0,5 I 
NaOH (necessary for fluorescence of free a-naphthol) and were 
immediately measured in a spectrofluorometer (as described above) 
Measurements were adjusted, for ’’blank" values, obtained by 
measuring the background fluorescence of serum-buffer-substrate 
media, with and without the three drugs, which had been incubated 
without leukocytes »*■ it will be remembered that alicylate was 
found to cause a sizeable background fluorescence at the wave¬ 
lengths used for measurements. The fluorescence measurements 
obtained from the media of non-phagocytizing cells were com¬ 
pared with measurements from media containing phagocytizing cells 
Slide preparations of leukocytes showed that substrate did not 
prevent phagocytosis. 
Results and Discussion 
Fig, 12 illustrates the increase of fluorescence (or 
free a-naphthol) in the extra-cellular media of phagocytizing 
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and non-phagocytizing leukocjrte cultures, indicating a rise in 
extra-cellular phosphatase activity with ingestion of bacteria 
by neutrophils. Table 3 represents values for the percentages o-f 
increased phosphatase activity in the culture media with phag¬ 
ocytosis for control and drug treated, groups after incubation 
periods of 1 hr 7 The increases in extra-cellular phosphatase 
activity with phagocytosis is less for colchicine and cortisol 
treated cultures than for controls, whereas the percentage of 
increased enzyme activity is slightly more for the salicylate- 
treated cultures. The values given in Table 3 represent 6 
experiments? variabilities were large and the means are statis¬ 
tically different at relatively high Mp" values. However, the 
differences among the drug-treated and control groups are 
consistent with the results of experiments presented above. 
__ ^ 
Percentages of Increased Phosphatase Activity 
in the Incubation Media with Phagocytosis 
Table 3 
Control Colchicine Na Salicylate Cortisol 
Mean values of 
Percentages 
Increased Enzyme 
Activity ±SEK 
It is important to note that "neutral" phosphatase activity 
(activity at pH 7.4) recovered from the leukocytes was found to 
be located almost entirely in the "granular" fraction, when 
cellular fractions were separated as previously described. It 
must be added that, although these results are compatible with 
these percentages are comparable to the figure of 73% noted in 
Fig, 12, which is the percent increased phosphatase activity 
found in the media of phagocytizing cells compared with phosphatas 
activity found in the media of non-phagocytizing cells (at fiomin.') 
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findings already presented concerning the actions of the three 
drugs studied, these experiments do not exclusively record extra¬ 
cellular enzyme activity. Phosphatase substrate was found to enter 
the leukocytes during phagocytosis (not unexpectedly) and to be 
broken down within the cells, as vas evidenced by the appearance 
of fluorescence within the leukocytes (fluormetric measurements 
were made on lysates of cells which had been separated from the 
media at various incubation times). At least a part of the in¬ 
creased phosphatase activity found in the incubation media with 
phagocytosis may represent free a-naphthol which had been split 
from the substrate within the cells and then leaked out into the 
* 
media. Certainly, these experiments demonstrate that colchicine 
and cortisol inhibit the intracellular mobilization of granule — 
associated enzyme activity; however, these experiments also provide 
evidence that these drugs inhibit the extra-cellular release of 
granular enzymes during phagocytosis. 
As is apparent in Fig, 12 there is phosphatase activity in the 
incubation media of non-phagocytizing cells, evidenced by rising 
concentrations of free a-naphthol during incubation; part of this 
rise represents phosphatase activity of the serum in the media; part 
of this rise represents instability of the a-naphthyl phosphate 
substrate; however, some of this rise also represents a reaction 
of the substrate with the non-phagocytizing cells, for which I have 
no explanation. 
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VI. SUMMARY AND CONCLUSIONS 
The role of the Polymorphonuclear Leukocyte (Neutro¬ 
phil) in natural protection against infectious disease has been 
recognized since the turn of the century. Now, this cell is also 
recognized to be of great importance as a mediator of tissue 
damage in a variety of acute inflammatory diseases in which the 
inflammatory stimuli are harmless without the inflammatory 
response which they provoke. The pathologic role of the neutro¬ 
phil has been delineated best in such experimental models of 
human disease as provided by the Arthus Phenomenon and crystal - 
induced acute arthritis, in which an inflammatory response and 
not stimulus is destructive to the animal or human host. 
In particular, the various digestive enzymes and spec¬ 
ific proteins bound in the granules of neutrophils have been 
proposed as the active agents contributed by neutrophils in 
mediating the tissue damage of acute inflammation. It is known 
that these granular enzymes and proteins are mobilized from their 
inactive, bound state during phagocytosis for purposes of destroy¬ 
ing ingested particles. Also, for some time it has been assumed 
that in acute inflammation these lytic agents become available 
in the extra-cellular spaces and cause tissue damage, and recently 
in various _in vitro experimental systems it has been demonstrated 
directly or indirectly‘that granular substances are released 
from neutrophils during phagocytosis. Such findings _in vitro 
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are compatible with several studies _rn vivo in which increased 
plasma or transudate fluid levels of neutrophil granular en¬ 
zymes have been found coincident with natural or experimental 
acute inflammation; in particular, lysozyme has been found to 
74 
be increased in various body fluids with acute inflammation -- 
75,76 
in fluids from acute arthritic joints, and in sera of 
rabbits injected with large numbers of bacteria or concentrated 
so 
suspensions of antigen-antibody complexes. 
In this report Tn vitro studies have been presented 
which Quantitate in detail the loss of lysozyme from human leuk¬ 
ocytes during phagocytosis together with the appearance of 
lysozyme in the extra-cellular incubation media. These studies 
have also quantitated the release of lysozyme during phagocytosis 
as a function of the time of phagocytosis and as a function of 
the phagocytic challenge. Kinetic studies of the release of lys¬ 
ozyme have shown that the release of the enzyme occurs during 
phagocytosis, not at a time when phagocytosis has been completed. 
These studies have also indicated that the release of lysozyme 
appears to approach a maximum at a certain high level of phagocytic 
challenge. Furthermore, these studies indicate that the release 
of lysozyme represents a process which is selective for granule- 
associated substances and does not represent destruction of 
the leukocytes; lactic dehydrogenase, a non-granular, cytoplasmic 
enzyme, was not found to be released during phagocytosis together 
with lysozyme. 
Other studies also presented demonstrate that two 
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anti-inflammatory drugs, cochicine and dortisol, inhibit the 
phagocytic release of lysozyme, A third anti-inflammatory drug, 
salicylate, did not affect the release of lysozyme, and the fail¬ 
ure of salicylate to affect this process of granular enzyme release 
is taken as strong evidence that this drug does not act upon 
this stage of the inflammatory process as has been previously 
suggested. 
Studies with acid phosphatase and cathepsin, neutrophil 
enzymes which are also bound to the granules of these cells and 
are also mobilized during phagocytosis, have demonstrated that 
these enzymes are lost from phagocytizing leukocytes as is lys¬ 
ozyme. Similarly the cellular loss of these enzymes during phag¬ 
ocytosis has been shown to be inhibited by colchicine and cortisol 
but not by salicylate. Obvious increases in acid phosphatase 
and cathepsin activity extra-cellularly were not found as a con¬ 
sequence of phagocytosis, in contrast to findings with lysozyme; 
however, further studies which demonstrated the relative instability 
of these two enzymes in solution offer a likely explanation for 
this finding. 
Studies, in which leukocytes phagocytized bacteria in 
the presence of phosphatase substrate, confirmed the findings 
of lysozyme experiments that granular enzymes appear in active 
form extra-cellularly during phagocytosis and that this process 
is inhibited selectively by colchicine and cortisol but not by 
Salicylate. 
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Although, as Metchnikoff suggested, disruption of neu¬ 
trophils may be an important mechanism in the release of lytic 
substances from neutrophils in acute inflammation, it is apparent 
that granular enzymes may be released from neutrophils during 
active phagocytosis without destruction of these cells. Recently 
it has been suggested that the release of granular enzymes from 
phagocytizing neutrophils may occur only with the ingestion of 
certain kinds of particles (eg, "indigestible particles"). 
However, the fact that release of granular enzymes has been 
demonstrated or suggested in studies with phagocytosis of a great 
variety of particles makes this proposition unlikely. The kinetic 
studies presented in this report relate the release of granular 
enzymes directly to the process of phagocytosis and not to an 
effect of the ingested particle upon the leukocyte once inside the 
cell. It was once thought that virus particles (or other particles 
of small size) were phagocytized by neutrophils but did not cause 
mobilization of granular enzymes within these cells; recent quantitative 
studies, however, have shown that as soon as viruses (opsonized 
by specific antibodies) are cleared from solution by neutrophils 
in vitro, the usual intracellular events of phagocytosis, in¬ 
cluding loss of granular enzymes, occur -- when leukocytes are 
incubated with viruses but do not undergo these intracellular 
10 
changes, they also fail to remove the viruses from solution. 
This same point has been made in an j_n vivo model: 
when sodium urate microcrystals of varying sizes are infused 
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into joint spaces, it appears that only crystals large enough 
to be ingested by neutrophils provoke an inf lamina tory response/ 
The observation that different neutrophil granular 
enzymes are, to varying degrees, unstable in solution would 
appear to be an important one. These instabilities most likely 
account for the decreased total enzyme activities found in leuk¬ 
ocyte cultures in which phagocytosis has occurred. The instabilities 
of granular enzymes may reflect an intracellular mobilization of 
enzyme inhibitors; in any case it is not unexpected that the potential 
dangers of the toxic granular substances might be naturally limited 
by short half-lives of enzymes once released into solution. 
One may postulate that the partial extrusion of granule-associated 
lytic enzymes from neutrophils during phagocytosis of invading 
micro-organisms is generally of no consequence to the host tissues 
because of the short half-lives of these enzymes when free in 
solution. The release of granular enzymes becomes of consequence 
in producing acute inflammation, however, with circumstances in 
which there exists sudden, localized, and intense phagocytosis. 
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